News
08-14-2025, 09:00 AM
Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise-and induced great disappointment.
More... (https://www.news-medical.net/news/20250814/Engineered-CD40-antibody-shrinks-tumors-and-induces-remission.aspx)
More... (https://www.news-medical.net/news/20250814/Engineered-CD40-antibody-shrinks-tumors-and-induces-remission.aspx)